Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment
1 other identifier
interventional
40
1 country
1
Brief Summary
This randomized, placebo-controlled, triple-blind trial aims to evaluate the effect of glutaraldehyde associated or not with 37% phosphoric acid conditioning on dentin hypersensitivity reduction after non-surgical periodontal treatment, and its durability after 15 and 30 days. desensitizing treatment. Additionally, investigate the impact of these treatments on health-related quality of life. The investigators selected patients who, after scraping and planing procedures, presented at least 2 teeth meeting the following inclusion criteria: presence of gingival recession without or with a periodontal pocket up to 5mm probing depth, which presented painful sensitivity response to tactile stimulus. and evaporative. Subjects were randomized into 3 groups: Placebo Group (GP) - Placebo Gel application followed by Placebo solution (distilled water); GPG- Placebo Gel application followed by application 5% aqueous glutaraldehyde solution; GSG - Application of 37% phosphoric acid followed by 5% aqueous glutaraldehyde solution. The sensitivity of the dental elements was evaluated by pain stimuli (tactile and evaporative) with the aid of a Visual Analog Scale (VAS). A questionnaire was applied to patients with the objective of capturing psychosocial experiences, prior to treatment and one month after its completion, to assess the impact of desensitizing treatment on health-related quality of life. Data will be collected and appropriate statistical tests will be applied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2019
CompletedFirst Submitted
Initial submission to the registry
December 16, 2019
CompletedFirst Posted
Study publicly available on registry
December 20, 2019
CompletedApril 21, 2020
April 1, 2020
9 months
December 16, 2019
April 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dentin sensitivity
Evaluation of pain (dentin sensitivity) by applying tactile (exploratory probe pressure) and evaporative (air blast) stimuli on exposed dentin. Sensitivity will be measured using the Thomas Schiff scale from 0 to 3. Zero means absent dentin sensitivity and three means severe dentin sensitivity.
Immediately after the intervention
Secondary Outcomes (1)
Dentin hypersensitivity experience questionnaire
Immediately after the intervention
Study Arms (3)
Placebo Group
PLACEBO COMPARATORPlacebo Gel + Placebo Solution (Distilled Water)
Placebo Gel + Glutaraldehyde (GPG)
EXPERIMENTALPlacebo Gel + 5% Glutaraldehyde Aqueous Solution
Phosphoric Acid + Glutaraldehyde (GAG)
EXPERIMENTAL37% Phosphoric Acid + Glutaraldehyde Aqueous Solution (GAG)
Interventions
Placebo gel application followed by placebo solution application (distilled water)
Placebo gel followed by 5% aqueous glutaraldehyde solution
37% phosphoric acid application followed by 5% aqueous glutaraldehyde solution
Eligibility Criteria
You may qualify if:
- \- Presence of gingival recession without or with periodontal pocket up to 5mm probing depth, which presented painful sensitivity response to tactile and evaporative stimuli.
You may not qualify if:
- Systemic diseases;
- Pulpitis;
- Carious lesions;
- Presence of restorations in selected teeth;
- Cracked enamel;
- Noncarious cervical lesions;
- Use of medication with analgesics and/or anti-inflammatories;
- Pregnant or lactating women;
- Desensitizing treatment and periodontal treatment received during three months prior to study recruitment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Para
Belém, Pará, 66075-110, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 16, 2019
First Posted
December 20, 2019
Study Start
March 15, 2019
Primary Completion
November 29, 2019
Study Completion
December 13, 2019
Last Updated
April 21, 2020
Record last verified: 2020-04